EP Patent

EP3730140A1 — Method of treatment with tradipitant

Assigned to Vanda Pharmaceuticals Inc · Expires 2020-10-28 · 6y expired

What this patent protects

This application relates to a method of treatment with tradipitant, and more particularly, to a method of treatment of pain, a behavioral stressor, craving, nausea, vomiting, substance dependence, or anxiety.

USPTO Abstract

This application relates to a method of treatment with tradipitant, and more particularly, to a method of treatment of pain, a behavioral stressor, craving, nausea, vomiting, substance dependence, or anxiety.

Drugs covered by this patent

Patent Metadata

Patent number: EP3730140A1
Jurisdiction: EP
Classification: —
Expires: 2020-10-28
Drug substance claim: No
Drug product claim: No
Assignee: Vanda Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.